Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Prostatic Neoplasms"
topic_facet:"Phase: Phase 2"
language:"English"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Prostatic+Neoplasms%22&filter%5B%5D=language%3A%22English%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Prostatic+Neoplasms%22&filter%5B%5D=language%3A%22English%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Prostatic+Neoplasms%22&filter%5B%5D=language%3A%22English%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
PubPharm (1.316)
1
Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer : Overcoming Drug Resistance in Metastatic Castration-resistant Prostate Cancer With Novel Combination of TGF-β Receptor Inhibitor LY2157299 and Enzalutamide: a Randomized Multi-site Phase II Study
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509) : Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone Acetate and Apalutamide (ARN-509) for Rising PSA After Radical Prostatectomy With Adverse Features.(FORMULA-509 Trial)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland : Clinical Study of Bioactivity of Low Dose Apalutamide in Prostate Cancer Patients Scheduled for Prostatectomy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer : A Phase 2 Study of M1774 in Refractory SPOP-Mutant Prostate Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer : Prospective Trial of Combination External Beam Radiation Therapy and MRI-guided, Dose-differentiated High Dose-rate Prostate Brachytherapy Boost for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC) : Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC) (BAT-RAD Study)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer : Phase II Trial of Primary Radiotherapy With Androgen Ablation With or Without Adjuvant Niraparib for Selected High-Risk Locoregional Prostate Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations : Phase 2 Study of CJNJ-67652000 (Niraparib/Abiraterone Acetate Fixed-Dose Combination) and Prednisone for Metastatic Castration-Resistant Prostate Cancer Associated With SPOP Mutation With or Without Homologous Recombination Deficiency
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node Metastasis : Pre-Surgical Androgen Deprivation Therapy With or Without Axitinib in Previously Untreated Prostate Cancer Patients With Known or Suspected Lymph Node Metastasis
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Addition of Opaganib to Androgen Antagonists in Patients With mCRPC : A Phase II Study of the Addition of Opaganib to Androgen Antagonists in Patients With Prostate Cancer Progression on Enzalutamide or Abiraterone
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[132]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Prostatic Neoplasms
Filter aufheben
Thema: Phase: Phase 2
Filter aufheben
Sprache: Englisch
Medienart
1.316
Aufsätze
1.316
E-Artikel
1.316
E-Ressourcen
Zeitschriftentitel
1.316
ClinicalTrials.gov
Thema
1.316
610
Phase: Phase 2
Prostatic Neoplasms
1.316
Study Type: Interventional
536
Recruitment Status: Completed
376
Medical Condition: Prostate Cancer
250
Recruitment Status: Recruiting
176
Recruitment Status: Active, not recruiting
171
Recruitment Status: Terminated
66
Carcinoma
61
Recruitment Status: Not yet recruiting
60
Recruitment Status: Withdrawn
55
Adenocarcinoma
52
Recruitment Status: Unknown status
49
Medical Condition: Prostatic Neoplasms
47
Neoplasms
28
Neoplasm Metastasis
28
Recurrence
24
Hypersensitivity
14
Medical Condition: Metastatic Prostate Cancer
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
792
2020-
503
2010-2019
21
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
Englisch
Haven't found what you're looking for?
Wird geladen...